In vitro susceptibilities of Aeromonas hydrophila against new antibiotics.
AUTOR(ES)
Fainstein, V
RESUMO
The antibiotic susceptibilities of 16 clinical isolates of Aeromonas hydrophila obtained from cancer patients with septicemia were studied. Of the new beta-lactam antibiotics tested, azthreonam and moxalactam were the most active, followed by cefoperazone, cefotaxime, and ceftizoxime. Excellent activity was demonstrated by chloroamphenicol, tetracycline, aminoglycosides, and trimethoprim-sulfamethoxazole. Semisynthetic penicillins had no appreciable activity against this organism.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=183774Documentos Relacionados
- In vitro susceptibilities of Mycoplasma genitalium to antibiotics.
- In vitro susceptibilities of Ehrlichia risticii to eight antibiotics.
- In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents.
- In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents.
- In vitro activity of cefoperazone against nonfermenters and Aeromonas hydrophila.
